Your session is about to expire
← Back to Search
Virus Therapy
Booster Dose of BNT162b2 Vaccine for Cancer
Phase 2
Recruiting
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks after booster dose
Awards & highlights
Summary
This trial will test if a booster shot of the COVID vaccine is safe and effective in cancer patients who didn't develop antibodies from the original vaccine series.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks after booster dose
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks after booster dose
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rates of seroconversion for SARS-CoV-2 spike antibody
Trial Design
1Treatment groups
Experimental Treatment
Group I: Booster doseExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Montefiore Medical CenterLead Sponsor
447 Previous Clinical Trials
582,674 Total Patients Enrolled
Albert Einstein College of MedicineOTHER
287 Previous Clinical Trials
11,856,586 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger